Poly Medicure Limited
Simbols: POLYMED.NS
NSE
1585.05
INRTirgus cena šodien
61.3484
P/E koeficients
311.8541
PEG koeficients
152.12B
MRK Cap
- 0.00%
DIV ienesīgums
Poly Medicure Limited (POLYMED-NS) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 3090.3 | 3516.7 | 3742.7 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 3019.7 | 3439.1 | 3693.1 | |||||||||||||||||
balance-sheet.row.net-receivables | 0 | 2357.3 | 2403.3 | 1884.5 | |||||||||||||||||
balance-sheet.row.inventory | 0 | 2086.5 | 1683.6 | 1264.8 | |||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 535.9 | 230.7 | 165.8 | |||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 8070.1 | 7834.4 | 7057.8 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 6623.8 | 4769.7 | 3910.2 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 285.8 | 285.8 | 285.8 | |||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 215.5 | 220.7 | 228.3 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 501.3 | 506.6 | 514.1 | |||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 89.7 | 204.2 | 508.6 | |||||||||||||||||
balance-sheet.row.tax-assets | 0 | 109.1 | 453.6 | 165.5 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 378.1 | 0 | 81.1 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 7702 | 5934 | 5179.5 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 0 | 15772.1 | 13768.3 | 12237.3 | |||||||||||||||||
balance-sheet.row.account-payables | 0 | 923.1 | 890.4 | 645.2 | |||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1301.7 | 882 | 721.8 | |||||||||||||||||
balance-sheet.row.tax-payables | 0 | 8.4 | 0 | 7.1 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 188.5 | 385.1 | 652.4 | |||||||||||||||||
Deferred Revenue Non Current | 0 | 27.4 | 35.3 | 43.3 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 328.5 | 230.7 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 422.8 | 626.8 | 867.6 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 25.8 | 14.3 | 32.9 | |||||||||||||||||
balance-sheet.row.total-liab | 0 | 3355.8 | 2893.5 | 2581.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 0 | 479.7 | 479.5 | 479.4 | |||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 5277.5 | 3990.4 | 3041.7 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 2730.4 | 2486.2 | 2216.2 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 3928.7 | 3918.7 | 3918.5 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 12416.3 | 10874.8 | 9655.7 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 15772.1 | 13768.3 | 12237.3 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-equity | 0 | 12416.3 | 10874.8 | 9655.7 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||
Total Investments | 0 | 189.7 | 286 | 578.3 | |||||||||||||||||
balance-sheet.row.total-debt | 0 | 1490.2 | 1267.1 | 1374.3 | |||||||||||||||||
balance-sheet.row.net-debt | 0 | 1419.5 | 1189.5 | 1324.7 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 2374.9 | 1952.4 | 1800.5 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 571.7 | 539.5 | 475.2 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -602 | -623.2 | -530.3 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 19.3 | 9.3 | 6.5 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -499.6 | -633.9 | -611.9 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | -288 | -507.4 | -332.3 | |||||||||||||||||
cash-flows.row.inventory | 0 | -402.9 | -418.8 | -143.9 | |||||||||||||||||
cash-flows.row.account-payables | 0 | 37.7 | 247 | 0.6 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 153.6 | 45.2 | -136.3 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 44 | -9.5 | 47.2 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2392.7 | -1555.8 | -951.3 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1.5 | 15.1 | 6.1 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -579.1 | -660.6 | -3444.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 577.6 | 645.4 | -6.1 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 602.6 | 702.5 | 39.8 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -1790.2 | -853.3 | -4355.8 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -209.9 | -62.8 | -664.5 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 3.5 | 1 | 4000 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -209.9 | 62.8 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -239.7 | -239.2 | 0 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 531 | -115.2 | -166 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -125.1 | -353.4 | 3169.5 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -7 | 28 | 1 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 70.6 | 77.6 | 49.5 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 77.6 | 49.5 | 48.6 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 1908.3 | 1234.7 | 1187.3 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -2392.7 | -1555.8 | -951.3 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -484.5 | -321.1 | 236 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 11152.3 | 9168.9 | 7750.4 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 4058.8 | 4332.3 | 3364.6 | |||||||||||||||||
income-statement-row.row.gross-profit | 0 | 7093.6 | 4836.6 | 4385.7 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0 | 361.9 | 35.5 | 12.3 | |||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 5011.4 | 3195 | 2683.1 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 9070.1 | 7527.3 | 6047.8 | |||||||||||||||||
income-statement-row.row.interest-income | 0 | 59.7 | 22.9 | 33.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 88.4 | 37.2 | 77.4 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 287.4 | 356.2 | 132 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 361.9 | 35.5 | 12.3 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 287.4 | 356.2 | 132 | |||||||||||||||||
income-statement-row.row.interest-expense | 0 | 88.4 | 37.2 | 77.4 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 571.7 | 539.5 | 475.2 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 0 | 2087.5 | 1596.2 | 1668.6 | |||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 2374.9 | 1952.4 | 1800.5 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 582.1 | 487.4 | 441.8 | |||||||||||||||||
income-statement-row.row.net-income | 0 | 1792.8 | 1465.1 | 1358.7 |
Biežāk uzdotie jautājumi
Kas ir Poly Medicure Limited (POLYMED.NS) kopējie aktīvi?
Poly Medicure Limited (POLYMED.NS) kopējie aktīvi ir 15772092000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.650.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 10.150.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.191.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.248.
Kāda ir Poly Medicure Limited (POLYMED.NS) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 1792825000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 1490168000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 5011373000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.